ArticleMolecules (Basel, Switzerland)2026
Non-Targeted Analysis of Carbofuran and Related Compounds in Commercial Formulations and Animal Tissue.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Recently, some cases of intentional animal poisoning using Carbofuran (CF) occurred in the Czech Republic, although CF is no longer available in the EU market. The present study describes a novel non-targeted analysis (NTA) workflow developed to possibly characterize 13 CF formulations from various sources to be certainly identified in real samples. Furthermore, a detection and quantification method for CF was developed for analyzing three animal samples, obtained from dead animals. The analyses were conducted using the liquid electron ionization (LEI) interface coupled with a quadrupole time-of-flight (QTOF) mass spectrometer, allowing the simultaneous characterization of the formulation's volatile and low-volatile fractions. Almost all compounds detected in the different formulations were identified by comparing the experimental spectra with the NIST library at high probability values (95-99.38%). Determination of molecular ions, followed by MS/MS analysis, was performed to confirm compound identities at a high level of confidence. The quantification method for CF was successfully validated, showing negligible matrix effects (107%). CF was detected in two out of the three real samples. Only 3-keto-carbofuran was detected in one of the real samples; without any other marker, it was not possible to identify the specific formulation used in the three poisoning cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.